Lesion monitoring parameters as predictors of atrial arrhythmia recurrence after catheter ablation in persistent AF: A DECAAF II sub‐analysis
Open Access
- 14 October 2024
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (12) , 2414-2422
Abstract
Background: The formation of transmural lesions is necessary for the ablation of persistent atrial fibrillation (prAF). Ablation index (AI) and generator impedance drop (ID) predict lesion size but their correlation with long‐term outcomes in prAF is not known. Furthermore, we proposed a new parameter, efficacy ratio (ER) calculated as ID/AI, to gain indirect insight into the role of factors affecting ID but not considered by AI.Methods: We included ablations performed during the DECAAF II trial if they had uploaded lesion‐by‐lesion summary data and were performed with radiofrequency catheters on the CARTO system. Average patient‐level parameters were calculated from all generated Vizitags.Results: A total of 427 ablations met inclusion criteria and 166 utilized AI. Analyzed as continuous variables, ID and ER predicted long‐term arrhythmia‐free survival but not AI. The ideal cut‐off for ID was ID ≥ 10.4 ohms and had a C‐index of 0.55. It predicted reduced risk of arrhythmia: hazard ratio 0.56 [0.36–0.88], p = .013 (arrhythmia‐free survival of 67% vs. 52%). Similarly, an ER of 1.7 ohms/100AI had a C‐index of 0.58 and predicted reduced arrhythmia recurrence: HR 0.39 [0.22–0.69], p = .001. ER < 1.7 ohms/100AI was related to just 32% arrhythmia‐free survival. ER improved prognostication as compared to ID alone and identified a subset of low ID patients with even worse outcomes.Conclusion: Average ID was predictive of improved outcomes following ablation of prAF. The ratio of ID/AI (ER) was postulated as a measure to summarize the overall impact of factors not considered in the AI formula and provided improved prognostication.Keywords
This publication has 13 references indexed in Scilit:
- Precision Medicine and Ablation of Ventricular ArrhythmiasJACC: Clinical Electrophysiology, 2023
- Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial FibrillationJAMA, 2023
- PO-697-04 WORSE ABLATION-INDUCED SCAR FORMATION ON FIBROTIC TISSUE: A SUB ANALYSIS FROM THE DECAAF IIHeart Rhythm, 2022
- Histopathological Characterization of Radiofrequency Ablation in Ventricular Scar TissueJACC: Clinical Electrophysiology, 2019
- Chamber-Specific Radiofrequency Lesion Dimension Estimation Using Novel Catheter-Based Tissue Interface Temperature SensingJACC: Clinical Electrophysiology, 2017
- Sites With Small Impedance Decrease During Catheter Ablation for Atrial Fibrillation Are Associated With Recovery of Pulmonary Vein ConductionJournal of Cardiovascular Electrophysiology, 2016
- Feasibility, Efficacy, and Safety of Radiofrequency Ablation of Atrial Fibrillation Guided by Monitoring of the Initial Impedance Decrease as a Surrogate of Catheter ContactJournal of Cardiovascular Electrophysiology, 2015
- Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillationEP Europace, 2015
- Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationJACC, 2013
- Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial FibrillationJAMA, 2010